logo-loader

Investor Update: IQ-AI rockets as it receives StoneChecker FDA clearance

Headlines from the Proactive UK newsroom.

IQ-AI (LON:IQAI) has received FDA clearance to market its StoneChecker Software in the US. IQ-AI said it was delighted with the decision.

Synairgen (LON:SNG) is to present biomarker data from the first part of its ongoing Phase II trial of its inhaled interferon beta therapy for COPD at a major European conference this month. Synairgen’s treatment is designed to bolster COPD sufferers’ defences against viral infections such as colds and flu.

Itaconix (LON:ITX) has been rated one of "The Top 50 Companies to Disrupt the World" by Biofuels Digest, the world's most widely-read daily publication on the bioeconomy.

Sareum (LON:SAR), another UK biotech, meanwhile will present details of how one of its discoveries significantly reduces tumour growth in disease models of many cancers next month in Boston. In pre-clinical work, Sareum’s treatment promoted an anti-tumour effect by activating the local immune system to attack cancer cells.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IQ-AI Limited named herein, including the promotion by the Company of IQ-AI Limited in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Ncondezi Energy submits updated financial model for Mozambique project to...

Ncondezi Energy Limited's (LON:NCCL) Hanno Pengilly speaks to Proactive London's Andrew Scott after announcing they've submitted an updated financial model for a 300MW power station at Tete in Mozambique to its partners for review. He adds that tariff submission remains on track for this...

17 minutes ago

2 min read